Jennifer Lew, CFO at Chinook Therapeutics, holds 82.06K shares in Annexon Biosciences (Ticker: ANNX), holds 135.16K shares in Chinook Therapeutics (Ticker: KDNY), holds 2.33K shares in Dynavax (Ticker: DVAX).

See the Hottest Stocks Based on Insider Trading >

Jennifer Lew
Chinook Therapeutics (KDNY)
CFO

Ranked #13,836 out of 98,564 Corporate Insiders

Profitable Transactions

8 out of 10 Profitable Transactions

Average Return

+11.30%

Average return per transaction

Time Frame

1 Year

Compare to

No Benchmark

How are Insiders Ranked?

Insider Holdings

93.00%

ANNX

7.00%

DVAX

A breakdown of Jennifer Lew's holdings

See the Top Stocks by Insiders

Insider Roles

Annexon Biosciences
(ANNX)

EVP & CFO

Dynavax
(DVAX)

VP, Finance & PAO

Roles that Jennifer Lew holds in companies

See the Top Corporate Insiders

Most Profitable Insider Trade

Stock:

Chinook Therapeutics
(KDNY)

Rating:Informative Sell

Date:Sep 14, 2018 - Sep 14, 2019

Return:+80.80%

The most profitable trade made by Jennifer Lew

See the Latest Stocks Traded by Insiders

Jennifer Lew's Trading History

KDNY

Chinook Therapeutics

May 03, 2019

―

Uninformative Sell

78.13K

$5.46M

ANNX

Annexon Biosciences

Feb 21, 2024

EVP & CFO

Uninformative Buy

―

$364.34K

DVAX

Dynavax

Sep 14, 2012

VP, Finance & PAO

Informative Sell

84.94K

$27.42K

List of latest transactions for each holding click on a transaction to see Jennifer Lew's performance on stock

See All Insider Trading from Today

Jennifer Lew insider profile FAQ

What is the percentage of profitable transactions made by Jennifer Lew?

The percentage of profitable transactions made by Jennifer Lew is 80%.

What is the average return per transaction made by Jennifer Lew?

The average return per transaction made by Jennifer Lew is 11.30%.

What stocks does Jennifer Lew hold?

Jennifer Lew holds: KDNY, ANNX, DVAX stocks.

What was Jennifer Lew’s latest transaction?

Jennifer Lew latest transaction was an Uninformative Buy of ―.

What was Jennifer Lew's most profitable transaction?

Jennifer Lew’s most profitable transaction was an Informative Sell of KDNY stock on September 14, 2018. The return on the trade was 80.80%.

What is Jennifer Lew's role in Chinook Therapeutics?

Jennifer Lew's role in Chinook Therapeutics is CFO.

How can I follow the stock ratings of top corporate insiders?

Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

Jennifer Lew Insider Profile

Jennifer Lew Chinook Therapeutics (KDNY)CFO